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INTRODUCTION 
 
 
  Surgical site infection is a dangerous condition and a heavy burden on the 
patient and social health system. Among hospital acquired infections it has been 
reported that due to surgical site infections are the main cause which is comprising 
around 14 to 16% of all inpatient infections. 
 
Surgical site infection incidence varies not just from one surgeon to other surgeon, 
but also from one hospital to other hospital, from one surgical procedure to other, 
and most importantly from one patient to another patient.  There are several factors 
contributing to the incidence. 
 
Major source for Surgical Site Infection from the Patient is skin as it a main 
source for pathogens that cause.  A reduction of these pathogens can significantly 
reduce the incidence of surgical site infections.   
 
There are many kinds of  preoperative skin antiseptics are available for 
preparation.  Povidone iodine and chlorhexidine are the commonly used antiseptics 
in clinical practice.  The present study has been made an effort to evaluate the 
efficacy of chlorhexidine alcohol over povidone iodine in elective clean and clean 
contaminated surgeries. 
 
The major concern is about the increasing incidence of surgical site 
infections.  Very few studies have been done in India to analyse the prevalence and 
risk factors of surgical site infections.  Hence this study was also done to analyse 
the prevalence, risk factors and impact of organisms in surgical site infections at a 
tertiary care hospital. 
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 ABSTRACT 
 
AIM 
To study the effect of chlorhexidine scrub on surgical site infection, in 
comparison with povidone iodine.  
 
OBJECTIVES: 
To assess the effect of Chlorhexidine scrub on surgical site infection over 
Povidone-Iodine. 
(I) To assess the microbiological organisms found in surgical site 
infections. 
(II) To assess the other risk factors contributing to the surgical site 
infections. 
METHODOLOGY 
300 patients who underwent elective surgeries from the department of 
general surgery, cardiothoracic surgery and pediatric surgery were prospectively 
studied.  Detailed clinical history, pre and post operative evaluation were done for 
all patients.  Patients were screened for any evidence of surgical site infection.  The 
microbiological profile was analyzed in detail for infected cases.                 
Patients were subjected into two groups. One group of patients underwent 
betadine scrub and the other group underwent chlorhexidine scrub pre operatively 
and were then compared using univariate analysis.  In order to identify the risk 
factor for the presence of surgical site infection, analysis by logistic regression 
were done.  Each patient was followed for a period of 30 days to assess the status 
of wound healing and any evidence of surgical site infection. 
The impact of surgical site infection was assessed by analyzing the 
associations of duration of hospital stay, any post operative complications, status of 
wound at the end of 30 days with any evidence  of surgical site infection using 
appropriate statistical tools.  The influence of other factors on surgical site 
infection were analysed by the same statistical tools. 
 
RESULTS 
Surgical site infections were isolated from 14 patients out of 300 (4.66%). 
50% of isolated organisms (7 out of 14) were found in surgical site. The 
commonest organism isolated in one study was Escherichia coli followed by 
Klebsiella  and Staphylococcus spp., by univariate analysis. Patient’s age, co 
morbid conditions, socio-economic status, length of hospital stay, ASA scoring, 
duration of surgery, skin closure type, obesity, were associated with significance in 
those with MDRO infected foot ulcers. 
Analysis by logistic regression indicated that about 3 factors significantly 
increased the risk of acquiring SSI infections. 
1. Skin closure type= suture, staples 
2. Duration of surgery 
3. Length of post op stay 
 
CONCLUSION 
Effect of chlorhexidine scrub showed significant reduction in surgical site 
infection.  Usage of chlorhexidine scrub as pre-operative skin preparation had 
significant reduction in surgical site infection when compared to the use of 
povidone iodine.  Factors  like type of cases (clean/clean contaminated), duration 
of surgery, length of hospital stay had significant impact in the development of 
surgical site infections. 
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 REVIEW OF LITERATURE 
 
Historical aspects 
 
Man, from time immemorial has been tending to his wounds.  The evolution 
of wound care evolved from witchcraft to potions and ointments.  Hippocrates, the 
father of medicine, used vinegar and wine to treat wounds.  Traditional Chinese 
medicine emphasised a holistic approach to wound healing, though none of it is 
relevant today.   
In ancient India, Sushrutha had a more systematic approach to wound 
healing.  Sushrutha Samahita had 2 chapters devoted to aspects of wound healing 
and the medicinal plants used to treat them. 
Even as recent as a century ago, prevention and treatment of surgical site 
infections proved to be a major challenge for the surgeons.  The world’s first 
antibiotic, Penicillin, was discovered only in 1928.  The surgeon did not have at 
hand the supportive treatments that are available now to treat infections.  Not least 
was the fact that there was a very poor understanding of the factors that led to 
wound infection. 
There were a few major landmarks in the 19th century.  Semmelweiss 
advocated hand washing, and use of antiseptic chlorinated lime solution.  Joseph 
Lister identified that wound infection could be prevented by following the 
principles of antisepsis.  Robert Koch recognized that microbial overgrowth led to 
infections.  
Joseph Lister (Professor of Surgery, London, 1827-1912) and Louis Pasteur 
(French bacteriologist, 1822-1895) revolutionized the entire concept of wound 
infection.  Lister was the first to recognize that antisepsis could prevent infection(1).  
The two world wars brought significant advancements in the understanding of 
surgical wounds.   
In older days health care providers and the environment has been focused on 
asepsis as a part of infection control measures. Therefore they made an effort and 
evaluated both decolonization and decontamination patients     
When a patients subjected in ICU AND develops Colonization of bacteria 
with MRSA he is known to increase the subsequent MRSA infection at higher 
incidence(2). There were, in addition, a few initiatives introduced to reduce the 
incidence of surgical site infection.   
Routine sterilization of instruments began as a practice in the late 19th 
century, though Galen, way back in 150 AD had advocated boiling of surgical 
instruments prior to their use.  Robert Koch and his team were the first to develop 
the steam sterilizer.  Use of gloves was first introduced by Bloodgood, a student of 
Halsted.  The role of wound debridement and delayed wound closure was put forth 
by Antoine Depage(3) 
With the use of appropriate and prophylactic antibiotics, the management of 
wound infections had a new revolution. Eradication of the source of infection 
affecting the surgical wounds is still being continued. This is because of several 
factors such as the emergence of antibiotic-resistant bacterial strains and implant 
surgery.  Further, the nature of more adventurous surgical interventions in immune 
compromised patients, has also been a factor. 
 
Surgical site infection- Introduction  
Surgical site infection (SSI) is a type of healthcare-associated infection in 
which a wound infection occurs after an invasive (surgical) procedure.  SSIs have 
been shown to comprise up to 20% of all of healthcare-associated infections.  An 
SSI may range from a spontaneously limited wound discharge within 7–10 days of 
an operation to a life-threatening postoperative complication.  
Most of surgical site infections are easily notified and preventable.   To 
reduce the risk of developing surgical site infections the care must be taken in all 
the phases of operative period (pre-, intra- and postoperative phases). The quality 
of life is significantly affected in case of patient with Surgical site infections and 
also relatively associated with morbidity and extended postoperative hospital stay.   
Murray et al(4) have shown that patients who have had SSI are twice as likely 
to develop incisional hernia.  Patients who have had infections, have a lower 
survival rate as opposed to those who haven’t(5).   
Most considerable another factor in the surgical site infections which is a 
financial burden for both patients and as well as healthcare providers.  There has 
been a recent study by Graf et al,(6 which showed that surgical site infections 
resulted in the cost of treatment being three fold.  
It may also be said that increasing numbers of infections are now being seen 
in primary care.  This is because patients are allowed to go home earlier following 
day case and fast-track surgery.   
The majority of SSIs become apparent within 30 days of an operative 
procedure and most often between the 5th and 10th postoperative days.  However, 
where a prosthetic implant is used, SSIs affecting the deeper tissues may occur 
several months after the operation. 
Surgical Site Infection –Definition(7) 
Surgical site infection (SSI) is a difficult term to define accurately because it 
has a wide spectrum of possible clinical features.The Centers for Disease Control 
and Prevention (CDC) have defined SSI to standardize data collection for the 
National Nosocomial Infections  
Surveillance (NNIS) program (8,9). SSIs are classified into Incisional SSIs, 
which can be superficial or deep, or organ/space SSIs, which affect the rest of the 
body other than the body wall layers.                                                  
Superficial Incisional Surgical Site Infection 
This is an infection, which occurs within 30 days of the surgical procedure 
and only involves skin and subcutaneous tissue of the incision, and at least one of 
the following:  
1.Purulent drainage with or without laboratory confirmation, from the superficial 
incision. 
2.Organisms isolated from an aseptically obtained culture of fluid or tissue from 
the superficial incision. 
3.At least one of the following signs or symptoms of infection: pain or tenderness, 
localised swelling, redness, or heat and superficial incision is deliberately opened 
by surgeon, unless incision is culture-negative. 
4.Diagnosis of superficial incisional SSI made by a surgeon or attending physician. 
Deep Incisional Surgical Site Infection 
Infection occurring within 30 days of the surgical procedure, if no implant 
has been left in place or within one year if implant is used and the infection 
appears to be related to the operation.  Further the infection involves deep soft 
tissue (e.g. fascia, muscle) of the incision and at least one of the following: 
1.Purulent drainage from the deep incision but not from the organ/space 
component of the surgical site. 
2.A deep incision spontaneously dehisces or is deliberately opened by a surgeon 
when the patient has at least one of the following signs or symptoms: fever 
(>38°C), localised pain or tenderness, unless incision is culture-negative. 
3.An abscess or other evidence of infection involving the deep incision is found on 
direct examination, during reoperation, or by histopathologic or radiologic 
examination. 
4.Diagnosis of deep incisional SSI made by a surgeon or attending physician. 
Organ/Space Surgical Site Infection 
Infection occurs within 30 days after the operation if no implant is left in 
place or within one year if implant is in place and the infection appears to be 
related to the operation and infection involves any part of the anatomy (e.g., organs 
and spaces) other than the incision which was opened or manipulated during an 
operation and at least one of the following: 
1.Purulent drainage from a drain that is placed through a stab wound into the 
organ/space. 
2.Organisms isolated from an aseptically obtained culture of fluid or tissue in the 
organ/space 
3.An abscess or other evidence of infection involving the organ/space that is found 
on direct examination, during reoperation, or by histopathologic or radiologic 
examination. 
4.Diagnosis of organ/space SSI made by a surgeon or attending physician. 
 
 
Incidence:-  
Surgical site infection rate is about one fifth of all healthcare associated 
infections.  The incidence of SSI greatly varies worldwide and is also different 
from hospital to hospital.  As per different studies, the rate of SSI ranges from 
2.5% to 41.9% (10).  In a majority of the reviews, the incidence has not been 
reported to be under 5%, even in the most favourable conditions and when clean 
surgeries are performed(11).   
Clean-contaminated surgeries have an SSI rate of 10%-16% and post-
discharge SSI is around 2%(11).  During 1986-1996, the NNIS (National 
Nosocomial Infections Surveillance) SSI rate was reported to be 2.6% for all 
operations across different hospitals in the United States(12). 
SSIs may take a few days to develop, and it may not become evident until 
after the patient has been discharged from hospital.  The true rate of SSI is 
underestimated by surveillance, which has focused on detecting SSI during the 
inpatient stay.  This problem is exacerbated due to increasing trend towards day 
care surgery and shorter length of hospital stay postoperatively(13).                     
The value of surveillance is enhanced only by the systems that enable cases 
of SSI being identified even after discharging the patient from hospital.  In 
community settings, there are a number of practical difficulties faced in identifying 
SSI reliably.   
It is also important that  valid comparisons of rates have to be made 
systematically and accurately in identifying the SSI(14). 
 
Factors leading to wound infection:- 
The risk of SSI is increased by certain factors. 
 Factors that increase the risk of endogenous contamination  (Procedures 
involving parts of the body with high concentration of normal flora such as the 
bowel) 
 Factors that increase the risk of exogenous contamination (Prolonged 
operations which may increase the time length of tissues that are exposed) 
 Factors that diminish the efficacy of the general immune response  
(example- diabetes, malnutrition, immunosuppression, radiotherapy, chemotherapy 
or steroids).   
 
 
 
 There are also other local immune responses like foreign bodies 
(including implants and prosthesis), formation of a hematoma and damaged or 
devitalized tissue.                                                                                                      
 
It is important to note that although infections may not manifest until after a 
few days, and sometimes even after discharge, there is a significant contribution 
from peri-operative factors. 
After analyses, it has been stated that the factors which are significant in one 
type of surgery may not be applicable to all other surgical procedures.  Certain risk 
factors have been listed below in detail. 
Age: 
In a prospective observational study, analysis of the data collected from 142 
medical centres, identified age as an independent risk factor for SSI(15).  There was 
a significant increase in the risk of SSI with patients aged above 40 when 
compared with those under 40 years of age. 
 
 
Underlying illness 
The ASA (American Society of Anesthesiologists) classification of physical 
status score is being used in assessing the patients’ preoperative physical condition.  
It provides a simple measure of severity of the underlying illness.  Several studies 
have shown that a poor ASA score is associated with greater degree of developing 
of SSI(15,16).                                                                                                                
The SSI incidence rate of 1.2% has been reported from a prospective cohort 
study for adult surgical patients from 11different hospitals(17).  A statistically 
significant higher incidence of SSI for those with an ASA score of 3 or more 
compared with those with an ASA score of 1 or 2 was reported.  It has been found 
that a significant higher risk of SSI in patients with an ASA score of 3 or greater 
was due to associated severe systemic disease. 
A number of studies in general surgery have shown that diabetes is strongly 
related with an increased risk of SSI(18-24).  Several studies, over the years, have 
shown that the associated diabetes has a strong increased risk of SSI, with as much 
as two to three fold. The reason may be related due to an altered cellular immune 
function.  Associated vascular and neurological complications as well as an 
increased propensity for developing infections put these patients at a higher risk of 
developing SSI. 
 
Malnourishment 
Malnourishment has a significant increase in the incidence of SSI.  One 
large prospective study of predominantly clean procedures on in children as well as 
adults, reported that the presence of malnourishment increases the incidence of SSI 
from 1.8% to 16.6% by univariate analysis.                                                             
A retrospective study on general surgical procedures, had shown a strong 
evidence associating the risk of SSI in patients with a low serum albumin(25). 
Another study had shown that significant weight loss in the preceding 6 months 
and post-operative anaemia are also associated(26). 
 
Obesity 
The risk of SSI increases in a patient with a body mass index of 35 kg/m2 or 
more(25).  Obesity has an effect on tissue oxygenation and immune response 
functioning.  This leads to poorly vascularised adipose tissue.  In addition, 
operations performed on obese patients are also more complex and time 
consuming(27).   
In a study on patients undergoing coronary bypass grafts, it was shown that 
pre-operative weight reduction significantly reduces SSI(28).  
 
Intra-operative events 
The three main intra-operative factors are hypotension, hypothermia and 
duration of surgery. 
Intra-operative hypotension leads to tissue hypo perfusion.  It could also be 
due to the fact that the more complex procedures are associated with this event. 
Hypothermia, which is sometimes seen in major and complex procedures, 
has been associated with wound infection.  Hypothermia leads to thermoregulatory 
vasoconstriction and therefore reduced tissue oxygenation.  It also decreases the 
immune response(29). 
The length of surgery has also been shown to be associated with SSI.  In a 
study on laparoscopic colorectal surgery, it was found that procedures exceeding 4 
hours were prone for wound infections(30). 
 
 
Smoking 
Studies had found that the smoking is associated with development of 
SSI(18,31).   Smoking cigarettes affects wound healing by the vasoconstrictive 
effects of nicotine and reduction in oxygen-carrying capacity of blood.   
Reduced tissue oxygenation also leads to decreased deposition of tissue 
collagen and therefore poorer wound healing.  It has been shown that there is a 
three fold increased risk of developing infections among smokers as opposed to 
non smokers. 
 
Wound classification 
For several years, it has been understood that there is a significant 
association of normally colonizing microbial flora at the operated site and 
subsequent development of SSI. 
Three studies had found the association of wound classification with 
incidence of SSI(16).  The data from an infection surveillance in a large 
retrospective analysis showed the incidence of SSI rate per 100 operations for 
clean, clean-contaminated, contaminated and dirty wounds as 2.1, 3.3, 6.4 and 7.1, 
respectively(16). 
 
Site and complexity of procedure 
Complexity of the operation is also indicated as a risk factor for an SSI.  A 
study on general and vascular surgery procedures, estimated a two- to three-fold 
increased risk of SSI with increasing surgical complexity(18).   
Similarly different rates of SSI have been reported for the same procedure 
being performed at different sites of the body.  For example, laminectomy done on 
the cervical spine is associated with a lower risk of SSI than laminectomy 
performed at other levels(32). 
 
Type of skin closure 
The two common methods of   skin closure after a surgery are sutures and 
staples.   
A large meta-analysis involving over 600 patients who have undergone 
orthopaedic procedures showed that there is a significantly higher infection rate 
when metallic staples are used for skin closure, as opposed to sutures(32). 
 
Others 
Radiotherapy and corticosteroids have also has been linked to an increased 
risk of SSI(33).   
 
Measures to reduce wound infection:- 
The risk of SSI is decreased when an intervention is taking place to reduce 
the skin microorganisms surrounding the incision. 
 
Preoperative showering 
Microbial flora in the skin consists of transient microorganisms which are 
acquired by touch that can be easily removed by washing with soap.  The skin 
appendages such as hair follicles, have resident flora that normally live in skin. 
These resident flora are not generally pathogenic but are not so easily removed by 
soap although usage of antiseptic may reduce their numbers.                                 
There are millions of bacteria contaminating the skin, but the number 
required to produce a surgical site infection is low particularly in the setting of an 
implant. 
One well-conducted systematic review examined the evidence for 
preoperative bathing or showering with antiseptics for the prevention of SSI(33). 
 
Hair removal 
The removal of hair is necessary to view the operative site adequately and to 
access the operative site.  Sometimes it is removed because of a persistent increase 
in the risk of microbial contamination at the operative site.   
During hair removal the micro-abrasions of the skin which are caused due to 
using razors for shaving may facilitate the multiplication of bacteria over the skin 
and skin surface.  This will happen, particularly, when it is undertaken several 
hours prior to the procedure.  This may subsequently lead to colonization of 
microorganisms in and around the skin, as a result of which, contamination of 
wound is facilitated and subsequent development of SSI(34).   
Therefore, hair removal, if considered necessary, should be done by the least 
traumatizing method and minimizing the extent of damage to the skin.  Further, the 
time interval between hair removal and surgery should be minimal.   
It is therefore recommended that it be done on the day of surgery using the 
electric clippers with a single-use head.  This will significantly reduce the 
development of SSI, as reported in this study(35). 
 
Nasal decontamination 
Staphylococcus aureus is found in the anterior nares.  It is the main reservoir 
for this pathogen.  It has been shown that these bacteriae multiply and migrate to 
the other skin surface area and the operated site. 
Measures can be taken to clean the carriage of S.aureus, and if done prior to 
surgery, SSI can be reduced(36). 
 
Mechanical bowel preparation 
Bacterial flora that colonize the patient’s skin, mucous membranes and 
gastrointestinal tract, and is the predisposing factor for the development of surgical 
site infection.  In elective colorectal surgeries, prior to the surgery it has been 
suggested removal of faecal matter from the rectum and colon confers an 
advantage(35).  Nowadays, mechanical bowel preparation for all intestinal surgery 
has become a fundamental component in many units.   
There are many reasons where the mechanical bowel preparation has been 
considered to be advantageous which includes operative time, ability to palpate the 
bowel wall lesions, easy way of handling the bowel and the rate of stoma 
formation, all of which may have an indirect association with SSI.   
However, there is no evidence that bowel preparation influences the 
incidence of SSI in patients undergoing colorectal surgery(35,37,38). 
 
Preparation of skin 
Since normal skin flora is also an aetiological agent of SSI, the patient’s skin 
is a potential source.  Preoperative skin disinfection, just prior to surgery, is 
effective in bringing down the microorganisms on the skin. 
Cleanliness of the skin is the most important factor determining efficacy of 
antiseptic agents.  Before applying the antiseptic agent, the superficial soil & 
debris present on the skin should be removed to reduce the risk of wound 
contamination.  Therefore, patients are advised to shower or have bath using soap 
either the night before or, preferably, on the day of surgery. 
Hair removal, as part of skin preparation, as such, has many contradicting 
views on its role in surgical site infection.  Studies have found that pre-operative 
shaving of the surgical site increases the risk of surgical site infection(39).  
Therefore, hair should be left whenever possible.  But, in case the presence of hair 
interferes with the surgical procedure then the following precautions should be 
taken. 
 Hair removal- performed on the day of surgery (location should be 
outside the operating theatre or procedure room). 
 Hair which interferes the surgical procedure should alone be removed.  
 Hair should be removed using a single use electric or battery operated 
clipper.  
 
The operative site should be free of all jewelry with preparation starting 
from the cleanest area to least clean area in a concentric fashion or from area of 
lower bacterial count to higher(40).  In case of procedure involving both abdomen 
and perineum, parts are prepared one after the other using separate depilator with 
abdomen preceding the perineum.   
The solution should remain in contact for adequate timing and allowed to 
dry naturally instead of using swab or sponges.  The prepared area should provide 
room for potential shifting of the drape, fenestration, new incisions or extension of 
the present incision and drain sites(39-42). 
 
Hazard precautions: 
The right volume of solution for an adequate contact period and drying time 
are essential to avoid skin irritation.  Fire or burn injuries occur when there is 
pooling of the solution beneath or around the patient.  The presence of excess hair 
can delay drying(41,43).                                                                                              
 
Product selection: 
Selection of the product will depend on  
 Patient’s sensitivity or allergy 
 The surgery site 
 The condition of the patient 
 The presence of organic matter 
 Preference of surgeon 
 Rates of SSI in the region 
 The ability to significantly reduce micro-organisms with a broad 
spectrum of action.  
The product should be non-irritating, non-toxic, rapidly acting with a 
persistent effect, and be compatible with other products for preparation. 
There are several antiseptic solutions being currently used, but the common 
two are chlorhexidine and povidone iodine. 
There are no randomized control studies comparing the efficacy of 
chlorhexidine with povidone iodine, and the last word on the superiority of one 
over the other is yet to be said(44). 
 
CHLORHEXIDINE:  METHOD OF ACTION, ADVANTAGES, 
SIDE EFFECTS 
Chlorhexidine is a topical antiseptic solution.  It has been used worldwide  
since 1954.  It has provided an excellent result and record of safety and efficacy of 
applications in both children and as well as adults.   
Commercially, chlorhexidine is available at a variety of concentrations 
ranging from 0.5%–4%.  It is also available with different formulations, that is 
with and without ethanol or isopropyl alcohol.  Studies have shown that it is 
preferable to use 2% chlorhexidine with 70% alcohol. 
It is diversely used as a preoperative skin preparation, hand washing, vaginal 
antisepsis, body washes to prevent neonatal sepsis and also as mouth washes for 
the treatment of gingivitis.  
 
Method of action 
Chlorhexidine gluconate, basically, is water-soluble and cationic biguanide 
in nature.  It binds and acts in a bacterial cell which is negatively charged resulting 
in altered osmotic equilibrium in the cell.   
Chlorhexidine affects membrane integrity at lower concentration, causing 
leakage of cellular contents and cell death.  At higher concentrations cell death 
occurs due to precipitation of cytoplasmic contents(45,46).  The action is immediate. 
It has a broad activity against gram-negative and gram-positive bacteria, 
facultative aerobes and anaerobes, some lipid enveloped viruses, yeasts and also 
HIV(47).  It reduces preoperative bacterial colonization, inhibits bacterial growth 
and decreases postoperative count.  Chlorhexidine is not sporicidal.   
The use of chlorhexidine has demonstrated the lower bacterial count and 
therefore less infection, in comparison with povidone iodine, in the following 
situations. 
 Care of urinary catheter care (Munoz Price et al)48 
 Surgical hand scrub (Lai et al)49 
 Wound dressing (Eardly et al)50 
 
Advantages 
At the surgical site incision, chlorhexidine has been shown to have a 
superior effect in reducing the skin colonization when compared with povidone-
iodine(51).  In addition, it has a residual activity on the skin that helps to prevent 
rapid re-growth of skin organisms and enhances the duration of skin antisepsis.   
After a single application, chlorhexidine achieves greater reduction in skin 
flora.  It also has longer residual activity than does povidone-iodine(52,53). 
When surgeons used chlorhexidine hand scrubs, there was a greater 
reduction in the numbers of bacteria on the skin, compared with the use of other 
antiseptic agents.  It was also seen that the bacterial count suppression was 
maintained up to 6 hours(52,53).   
Chlorhexidine, unlike the iodophors, is active even in the presence of blood 
or serum proteins.   
There is extensive data demonstrating the reduction in skin flora resulting 
from use of these products, but again, there is no clear comparison demonstrating 
superiority of either of these products in reducing SSIs(54). 
  
Side effects 
Chlorhexidine has a long-standing track record of being a safe and effective 
product with broad antiseptic activity and little evidence of emerging resistance of 
the microorganisms to it.  For decades, chlorhexidine has been a well-tolerated, 
broadly used, skin and mucous membrane disinfectant.   
The most frequent adverse reaction to chlorhexidine is contact dermatitis.  
but rare cases of hypersensitivity and anaphylaxis have been reported(55).  Contact 
of chlorhexidine with the inner ear may result in permanent hearing loss(56).   
Strong solutions have been known to cause irritation of conjunctiva.  
Anaphylaxis has also been reported. 
 
  
POVIDONE - IODINE:  METHOD OF ACTION, ADVANTAGES, 
SIDE EFFECTS 
Povidone iodine the most widely used Iodophor which is a stable chemical 
complex of elemental iodine and polyvinylpyrrolidone.(57)  
It is a valuable antiseptic which has been recognized for more than a 
century.  It has been traditionally used as a preoperative antiseptic by surgeons.  
Povidone-iodine is a broad spectrum antiseptic which is used for topical 
application in the treatment and also prevention of infection in wounds. 
 
Method of action 
Iodine is an effective broad-spectrum bactericide and effective against 
viruses, fungi, yeasts, molds, and protozoans.  It is a broad spectrum microbicidal 
that helps in destroying microbial protein and DNA.  It oxidizes cell constituents, 
iodinates proteins and inactivates them. 
The chemistry of povidone-iodine is complex and not well understood.  
Therefore, the phenomenon of increased bactericidal activity with dilution is 
difficult to explain.  One hypothesis is that the concentration of "free" iodine (i.e., 
the elemental iodine in solution) significantly contributes to the bactericidal 
activity of povidone iodine solution(58).                                                             
The high degree of bactericidal efficiency with respect to highly resistant 
gram-positive pathogenic micro-organisms, such as methicillin-resistant 
Staphylococcus aureus (MRSA) andEnterococcus strains, has made the agent 
particularly useful and significant for hospital hygiene.  Cheaper than topical 
antibiotics, it is recognized as a staple solution for preparing the eye for surgery.   
Evidence has also recently indicated the antiviral activity of povidone-iodine 
against viruses like herpes simplex and adenoviruses and enteroviruses, as well as 
reaffirmed its high degree of efficiency against Chlamydia.   
 
Advantages 
It has many potential advantages including broader antibacterial spectrum, 
lack of identifiable bacterial resistances and significantly lower price.   
The microbicidal action spectrum of povidone iodine (PI) is broad, even 
after short exposure times. 
 
These preparations have widespread popularity today, attributable to their 
absence of odor, staining and lack of skin irritation. However, recent confirmation 
of intrinsic contamination of a 10% povidone-iodine solution with Pseudomonas 
cepacia startled many microbiologists and chemists considered experts in the 
antiseptic and disinfectant field(59,60).                                                                  
Unlike local antibiotics and other antiseptic substances, no resistance seems 
to develop.  Recently povidone-iodine has been found application in the field of 
nanomaterials. 
 
Disadvantages 
The side effects include  
 Severe pain on application 
 Irritation 
 Pruritic 
 Erythema and sometimes oedematous erythema 
 Acneform eruption. 
Apart from a moderate action, it has a disadvantage of a delayed drying 
time.  The optimal time is approximately 3 minutes.  Quite often the practice is to 
quickly dry with a sterile towel, in order to start the surgery, thus compromising on 
its efficacy(61). 
Further, it has been noted povidone iodine sometimes leaves a stain, that is 
difficult to remove.  Attempts to remove  will result in further skin irritation. 
 
CHORHEXIDINE vs POVIDONE IODINE 
Povidone-Iodine is not considered today the most efficient disinfectant of 
the surgical field in the prevention of Surgical Site Infections and the major 
infection risk is reported to drop to 9% with Chlorhexidine in case of a 16%with 
Povidone-Iodine disinfection(75,76). 
Chlorhexidine has been demonstrated to be superior to Povidone-Iodine 
solution for reducing colony formed units(CFU). There was evidence from one 
study suggesting that pre-operative skin preparations with Chlorhexidine in 
methylated spirits let to a reduced risk of surgical site infections compared with an 
alcohol based Povidone Iodine solution(78). 
No of studies have been conducted United states and as well as in India and 
reported as Chlorhexidine is better antisepsis for pre-operative skin preparation 
than the Povidone-Iodine preparation. 
In conclusion the simplicity of use and liking of Povidone-Iodine are good, 
made exception for the long drying time that sometimes pushes the surgeon to use 
a paper towel to absorb the residual fluid ,and shorten the required time of action. 
Sometimes resulting change of glove due to contamination. 
The alternative product Chlorhexidine has many advantages and eliminates 
part of these drawbacks. Its action is faster and its activity persists independently 
from the contamination by body fluids, it presents a residual effect. It does not 
require auxiliary material for the application and drying. It does not drip off the 
surgical field and it does not make a mess and allows a better sticking og the 
surgical drapes for bordering of the field.  
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METHODOLOGY 
 
This study is a randomized control study conducted to find the effect of 
chlorhexidine scrub on surgical site infection over Povidone- Iodine.                
The present study was conducted on patients admitted for surgery in various 
departments like General Surgery, Paediatric Surgery, and Cardiothoracic 
&Vascular Surgery units of PSG Institute of Medical Science and Research Centre. 
A total number of 300 clean and clean contaminated elective surgeries in 
various departments (as mentioned above) from September 2014 to May 2015 
were included in the study.  Written informed consents were obtained from the 
patients.  The patients were assessed pre-operatively, intra-operatively and post-
operatively.  Detail clinical history of the patient and other relevant data were 
collected using structured case report forms.  
For each of the patients, the following details were entered: age, sex, BMI, 
socio-economic status, diagnosis, surgery done, any co-morbid conditions, 
personal habits, nutritional status, haemoglobin level, type anesthesia, type of 
surgery by CDC definition, duration of the surgery, prophylactic antibiotic usage, 
pre-operative skin preparation, pre-operative scrub used – Chlorhexidine/ Povidone 
Iodine, wound closure, length of pre-op and post-operative stay was assessed.  
Each patient was followed up from the time of admission till discharge from the 
hospital and also for 30 days post-operatively.  
After assessing preoperatively, patients were subjected into two groups B & 
C group respectively by randomization.  The B group patients were subjected to 
povidone iodine scrub pre-operative surgical site painting, whereas the C group 
patients were subjected to chlorhexidine scrub. 
Post operatively patients were monitored for the development or any 
evidence of surgical site infection.  Surgical wound was inspected at the first time 
of dressing, at the time of discharge and weekly thereafter for 30 days.  Wound 
infection was diagnosed, if any one of the following criteria were fulfilled; serous 
or non-purulent discharge from the wound with signs of inflammation (edema, 
redness, warmth, fever, tenderness, induration, localized warmth), wound gape, 
wound dehiscence, other wound complications like haematoma, bleeding.       
Wound swabs were obtained from the floor of surgical site. Direct 
microscopic examination and aerobic cultures were done by standard methods.  
The bacteriological spectrum and the sensitive antibiotics were noted for each 
patient after which antibiotics was given accordingly.  Management of wound 
infection is also assessed in detail with patient outcome.  
For analyzing the factors influencing the surgical site infection, the patients 
were grouped into clean and clean contaminated cases.  The data was collected and 
entered in the SPSS data sheet.  The data was analyzed using SPSS 20 for 
descriptive statistics. 
The test variables were compared using chi-square test for qualitative 
variables and student’s test for quantitative variables.  The variables for which the 
association was statistically significant (p<0.1) were introduced in a logistic model 
to explain the presence of SSI. 
The impact of SSI was assessed by analyzing the mean duration of hospital 
stay and outcome of the patient, using the above said statistical tools. 
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AIM 
 
 
 
 
 
 
 
 To study the effect of chlorhexidine 
scrub on surgical site infection 
 
 To analyze the other factors 
influencing surgical infection 
 
 
 To analyze the microbiological 
organisms in surgical site infection 
 
  
 
STUDY DESIGN 
 
 
A prospective hospital based observational 
study 
 
 
 
STUDY POPULATION 
 
 
 
Selective patients from general surgery, 
cardiothoracic surgery, peadiateric surgery 
over a period (Sep2014-May2015) were 
included in the study 
 
 
SAMPLE SIZE 
 
300 
  
 
 
INCLUSION  
CRITERIA 
 
 
 
Elective open surgery  
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EXCLUSION 
CRITERIA 
 
 
 Emergency/laparoscopy surgery 
 Allergic to chlorhexidine 
 Immuno compromised patients 
 Those who do not consent  
 
 
DURATION OF STUDY 
  
        9months 
 
STUDY PERIOD  
 
Sep2014-May2015 
 
                                      PROFORMA 
 
 
Study No:   
 
Name : 
 
Age: 
 
Sex:  
 
Dept /Unit : 
 
IP No :  
 
OP No :     
 
Date of admission: 
 
Date of discharge :                            
 
Weight in kgs-: 
 
Ht :  
 
 
BMI :                                                               
 
 
Occupation : 
 
SES :                                                   
 
 
Diagnosis: 
 
 
Any Co morbid conditions (Hypertension /Diabetes Mellitus/ Immunosuppression/ etc)– Yes / No 
 If Yes,mention the condition and whether controlled……………………………………. 
 
 
 
Personal Habits – Smoking / Alcohol                                                                                      
Bar code 
 
 
 
 
 
Nutritional status : 
 
 
Haemoglobin : 
 
 
Type of Anaesthesia& ASA Score : 
 
 
Prophylactic Antibiotic given– Yes / No 
If Yes, name of the antibiotic and when given  
 
 
Skin preparation: 
 
 
Preoperative scrub used – Chlorhexidine or Povidone-iodine 
 
 
Type of surgery: Clean / Clean Contaminated  
 
 
 
Duration of surgery in hours: 
 
 
 
OT No: 
 
 
 
Wound closure:  Staples / Suture / Steristrips / Other 
 
 
 
 
 
 
                                                                                                                                                                                 
Did the patient develop SSI- Yes/No– 
 If Yes –  
o When did the infection develop -  
o Describe the infection – 
 Erythema 
 Wound gape 
 Wound dehiscence 
 Discharge 
o Culture sensitivity report – 
 
 
Other wound complications :  Haemotoma / Bleeding / Other 
 
 
Length of postoperative hospital stay: 
 
 
Management of infection (if any) details : 
 
 
 
 
Patient Out come : 
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RESULTS 
 
300 patients undergoing elective surgeries, 100 each from the departments of 
CTVS, Paediatric Surgery & General Surgery, were included in this study, after 
obtaining their consent.  36.3% of the patients were 50 years or older with the 
average age being 58.3 years.  70.7% of the patients were males, showing a distinct 
male preponderance.  Most (49.3%) belonged to class III socio-economic status 
followed by class II (30.0) as per Modified Prasad’s Classification (Table 1) 
 
Table 1:  (Demographic details) 
               Variable                 Number            Percentage 
 
 
AGE DISTRIBUTION 
<10Yrs 
10-30Yrs 
30-50Yrs 
>50Yrs 
 
 
92 
17 
82 
109 
 
 
30.7 
5.7 
27.3 
36.3 
SEX DISTRIBUTION 
Male 
Female 
 
 
212 
88 
 
70.7 
29.3 
SOCI-ECONOMIC 
STATUS 
Class I 
Class II 
Class III 
Class IV 
Class V 
 
 
27 
90 
148 
35 
0 
 
 
9.0 
30.0 
49.3 
11.7 
0 
 
 
The two groups (povidone iodine and chlorhexidine) are more or less evenly 
matched, as shown in the following table 
 
Table 2:  Demographic details of the two groups 
Variable Povidone Iodine Chlor-hexidine Total 
 
AGE DISTRIBUTION 
 
<10Yrs 
10-30Yrs 
30-50Yrs 
>50Yrs 
 
 
47   (51.1%) 
11   (64.7%) 
39   (47.6%) 
53   (48.6%) 
 
 
47    (51%) 
6   (34.3%) 
43   (52.4%) 
56   (51.4%) 
 
 
92 
17 
82 
109 
 
SEX DISTRIBUTION 
Male 
Female 
 
 
101  (47.6%) 
49   (55.7%) 
 
111  (52.4%) 
39  (44.3%) 
 
212 
88 
SOCIO-ECONOMIC 
STATUS 
 
Class I 
Class II 
Class III 
Class IV 
Class V 
 
 
 
9   (33.3%) 
49   (54.4%) 
76   (51.4%) 
16   (45.7%) 
0 
 
 
 
18   (66.7%) 
41   (45.6%) 
72   (48.6%) 
19   (54.3%) 
0 
 
 
 
 
27 
90 
148 
35 
0 
 
 
 
Co-morbid conditions like Systemic Hypertension, Type II Diabetes 
Mellitus, & other medical conditions were found in 34.7% of patients.  A majority 
of the patients (78.7%) were neither smokers nor consumers of alcohol.   
 Table 3  Co-morbid Conditions & Personal Habits 
Variable Number % 
 
 
Co-morbid conditions present 
Absent 
 
 
104 
196 
 
 
34.7 
65.3 
 
Alcohol and/or smoking history 
Nil 
 
 
64 
236 
 
21.3 
78.7 
 
The following table will show that the two groups (povidone iodine and 
chlorhexidine) are more or less evenly matched (Tables 4). 
 
Table 4 
              Variable     Povidone Iodine              Chlor-hexidine 
 
 
Co-morbid conditions Absent 
Present 
 
 
100 (51.0%) 
50 (48.1%) 
 
96 (49.0%) 
54 (51.9%) 
 
Alcohol and/or smoking history 
Nil 
 
 
26 (40.6%) 
124 (52.5%) 
 
38 (59.4%) 
112 (47.5%) 
 
 
Table 5:  Site of surgery & ASA grading 
 
                Variable 
 
             Number               Percentage 
Site of surgery 
 
Abdomen 
Scrotum 
Groin 
Chest 
Perineum 
Limbs 
Back 
Breast 
Neck & Cheek 
Axilla 
 
 
55 
20 
49 
98 
14 
23 
2 
17 
21 
1 
 
 
18.3 
6.7 
16.3 
32.7 
4.7 
7.7 
0.7 
5.7 
7.0 
0.3 
 
ASA Grading 
 
I 
II 
III 
IV 
V 
 
 
81 
180 
39 
0 
0 
 
 
27.0 
60.0 
13.0 
0 
0 
 
  
 
 
35% 
65% 
CO MORBIDITIES 
PRESENT ABSENT
ABSENT PRESENT
100 
50 
96 
54 
COMORBIDITIES 
POVIDONE IODINE CHLORHEXIDINE
  
 
18% 
7% 
16% 
32% 
5% 8% 
1% 
6% 
7% 
0% 
SITE OF SURGERY 
Abdomen
Scrotum
Groin
Chest
Perineum
Limbs
Back
Breast
Neck&Cheek
Axilla
27% 
60% 
13% 
0% 0% 
ASA GRADING 
I
II
III
IV
V
The commonest site of surgery in this study, as seen in the table above 
(Table 5) was the chest (32.7%) followed by abdomen (18.3%).  The least common 
site was axilla (0.3%).  As per the ASA (American Association of 
Anaesthesiology) grading system, most of the patients were found to fall under 
grade II (60.0%) who are liable to have mild systemic disease.  The following table 
will show that the two groups (povidone iodine and chlorhexidine) are more or less 
evenly matched (Table 6). 
Table 6:   
        Variable 
 
                             Number  
SITE OF 
SURGERY 
 
Abdomen 
Scrotum 
Groin 
Chest 
Perineum 
Limbs 
Back 
Breast 
Neck&Cheek 
Axilla 
Povidone Iodine Chlor-hexidine     P value 
 
31   (56.4%) 
4   (20.0%) 
19   (38.8%) 
51   (52.0%) 
10   (71.4%) 
11   (47.8%) 
2   (100.0%) 
11   (64.7%) 
10   (47.6%) 
1   (100.0%) 
 
 
24   (43.6%) 
16   (80.0%) 
30   (61.2%) 
47   (48.0%) 
4   (28.6%) 
12   (52.2%) 
0   (0%) 
6   (35.3%) 
11   (53.4%) 
0   (0%) 
 
 
 
 
 
      .037 
ASA Grading 
 
I 
II 
III 
 
 
 
43   (53.1%) 
92   (51.1%) 
15   (38.5%) 
 
 
38   (46.9%) 
88   (48.9%) 
24   (61.5%) 
 
 
 
                                                                                                                                 
 
 
31 
4 
19 
51 
10 11 
2 
11 10 
1 
24 
16 
30 
47 
4 
12 
0 
6 
11 
0 
SITE OF SURGERY 
POVIDONE IODINE CHLORHEXIDINE
I II III
43 
92 
15 
38 
88 
24 
ASA GRADING 
POVIDONE IODINE CHLORHEXIDINE
A majority of the cases were clean cases (81%) and the rest clean 
contaminated.  Most of the patients (73.3%) had duration of surgery lasting 
between 1 to 5 hours, as seen in Table 7.   
 
Table:7 
Variable 
 
Number Percentage 
TYPE OF SURGERY 
 
Clean cases 
Clean contaminated cases 
 
 
 
243 
57 
 
 
81.0 
19.0 
DURATION OF SURGERY 
 
<1hour 
1-3 hrs 
>3hrs 
 
 
 
56 
220 
24 
 
 
18.7 
73.3 
8.0 
 
Table 8 shows that the two groups (povidone iodine and chlorhexidine) are 
more or less evenly matched. 
 
 
 
Table:8 
  Variable 
 
          Number P value 
TYPE OF SURGERY 
 
Clean cases 
Clean contaminated cases 
POVIDONE-
IODINE 
CHLOR-
HEXIDINE 
 
115   (47.3%) 
35   (61.4%) 
 
128   (52.7%) 
22   (38.6%) 
 
 
.103 
DURATION OF 
SURGERY 
 
<1hour 
1-3 hrs 
>3hrs 
 
 
 
24   (42.9%) 
109   (49.5%) 
17   (70.8%) 
 
 
32   (57.1%) 
111   (50.5%) 
7   (29.2%) 
 
 
<0.05 
 
 
 
81% 
19% 
TYPE OF SURGERY 
CLEAN CASES
CLEAN CONTAMINATED CASES
                                                                                                                       
 
 
<1HOUR 1-3HOURS >3HOURS
56 
213 
17 
0 7 7 
DURATION OF SURGERY 
ABSENT PRESENT
CLEAN CASES CLEAN CONTAMINATED CASES
115 
38 
128 
22 
TYPE OF SURGERY 
POVIDONE IODINE CHLORHEXIDINE
                                              
             
With regard to type of wound closure, 97.7% of patients had the closure 
done by suturing.  The history of length of post-operative stay revealed that 42.3% 
of cases taken for study had only 5 days of hospitalization and almost an equal 
number between 5 and 10 days.  15.7% had an extended post-operative stay of 10 
or more days (Table 9). 
 
 
 
0
20
40
60
80
100
120
<1HOUR 1-3HOUR >3HOURS
24 
109 
17 
32 
111 
7 
DURATION OF SURGERY 
POVIDONE IODINE
CHLORHEXIDINE
Table 9 
Variable Number % 
TYPE OF CLOSURE 
 
Sutures 
Staplers 
 
 
293 
7 
 
 
97.7 
2.3 
POST OPERATIVE STAY 
 
<5days 
5-10days 
>10days 
 
 
 
127 
126 
47 
 
 
42.3 
42.0 
15.7 
 
 
Table 10 
Variable Number 
 
TYPE OF CLOSURE 
 
Sutures 
Staplers 
 
POVIDONE-
IODINE 
CHLOR-HEXIDINE 
 
149   (50.9%) 
1   (49.1%) 
 
144   (49.1%) 
6   (85.7%) 
POST OPERATIVE STAY 
 
<5days 
5-10days 
>10days 
 
 
 
58   (45.7%) 
61   (48.4%) 
31   (66.0%) 
 
 
69   (54.3%) 
65   (51.6%) 
16   (34.0%) 
 
  
 
 
98% 
2% 
TYPE OF CLOSURE 
SUTURE
STAPLER
0%
20%
40%
60%
80%
100%
SUTURE STAPLER
TYPE OF CLOSURE 
POVIDONE IODINE CHLORHEXIDINE
  
 
<5days 5-10days >10days
126 121 
39 
1 5 
8 
LENGTH OF POST OP STAY 
ABSENT PRESENT
<5DAYS
5-10DAYS
>10DAYS
58 61 
31 
69 
65 
16 
LENGTH OF POST OP STAY 
POVIDONE IODINE CHLORHEXIDINE
 It was found that out of the total number 300 cases included in the study, 14 
patients (4.7%) had been found to have the evidence of surgical site infection.  
50% of these patients had an organism grown from the wound, while in the rest 
there was only macroscopic evidence of wound infection. 
The rate of wound infection was looked at the two groups. 
Table 11 shows 8% of those scrubbed with Povidone Iodine (12 patients out 
of 150) had surgical site infection(SSI), while in the Chlorhexidine group, it was 
1.3% (2 out of 150 patients). 
 
TABLE : 11 
         
        SCRUB 
                              SSI  
         P value 
        Absent         Present 
 
Povidone-iodine 
Chlorhexidine 
 
138(92.0%) 
148(98.7%) 
 
12(8.0%) 
2(1.3%) 
 
           
0.103 
 
 
FACTORS ASSOCIATED WITH SURGICAL SITE 
INFECTIONS: 
The factors associated with surgical site infections were analyzed.  The test 
variables were compared using Chi-square test for qualitative variables and 
student’s test for quantitative variables.  The variables for which the association 
was statistically significant (p<0.05) were introduced in a logistic model to explain 
the presence of surgical site infection(Tables 12-21). 
Results of the univariate analysis showed site of surgery,  duration of 
surgery, type of closure and length of post operative stay were significantly 
associated with surgical site infection.  However logistic regression indicated that 
only factors significantly increased the chances of acquiring surgical site infection 
were duration of surgery, type of closure and length of post operative stay (Table 
20,21,22).    
The association of factors like age and sex of the patient, socio-economic 
status, co-morbid conditions like diabetes mellitus, systemic hypertension etc, 
personal habits like smoking and alcohol, ASA (American Society of Anaesthesia) 
grading, type of surgery with surgical site infected cases were statistically 
insignificant (Tables-12-19). 
 
TABLE : 12 
         AGE                               SSI         P value 
 
 
<10years  
 
10-30 years 
 
30-50 years 
 
> 50 years 
 
        Absent         Present  
 
              
        
    0.275 
         
90(97.8%) 
 
17(100%) 
 
78(95.1%) 
 
101(92.7%) 
            
2(2.2%) 
 
0(0%) 
  
4(4.9%) 
 
 8(7.3%) 
 
 
TABLE : 13 
          SEX                               SSI         P value 
 
 
MALE 
 
FEMALE 
 
        Absent         Present  
 
          
0.949 
 
 
202(95.3%) 
 
84(95.5%) 
 
10(4.7%) 
 
4(4.5%) 
 
 
TABLE : 14 
 
Socio-economic status  
SSI  
P value Absent Present 
 
I 
II 
III 
IV 
V 
 
26(96.3%) 
85(94.4%) 
141(95.3%) 
34(97.1%) 
0 
 
1(3.7%) 
5(5.6%) 
7(4.7%) 
1(2.9%) 
0 
 
 
 
0.924 
 
TABLE : 15 
         
          SITE 
                              SSI  
         P value         Absent         Present 
 
     Abdomen 
     Scrotum 
     Groin 
     Chest 
     Perineum 
     Limbs  
     Back 
     Breast 
     Neck & Cheek 
     Axilla 
 
 
48(87.3%) 
20(100%) 
48(98.0%) 
92(93.9%) 
14(100%) 
23(100%) 
2(100%) 
17(100%) 
21(100%) 
1(100%) 
 
7(12.7%) 
0(0%) 
1(2.0%) 
6(6.1%) 
0(0%) 
0(0%) 
0(0%) 
0(0%) 
0(0%) 
0(0%) 
 
 
 
 
          0.120 
 
TABLE : 16 
         
CO-MORBIDITIES 
                              SSI  
         P value 
        Absent         Present 
 
YES 
 
NO 
 
 
96(92.3%) 
 
190(96.9%) 
 
 
8(7.7%) 
 
6(3.1%) 
 
 
           0.070 
 
 
 
 
TABLE : 17 
 
PERSONAL HABITS 
                              SSI  
         P value 
        Absent         Present 
 
NO 
 
YES 
 
225(95.3%) 
 
61(95.3%) 
 
11(4.7%) 
 
3(4.7%) 
 
        0.993 
 
 
 
 
TABLE : 18 
 
 ASA-Grading 
                              SSI  
         P value 
        Absent         Present 
 
I 
 
               II 
 
III 
 
81(100%) 
 
169(93.9%) 
 
36(92.3%) 
 
0(0%) 
 
11(6.1%) 
 
3(7.7%) 
 
 
       
   0.060 
 
 
TABLE : 19 
 
TYPE OF SURGERY 
                      SSI  
         P value  
    Absent     Present 
 
Clean cases 
 
Clean-contaminated cases 
 
 
234(96.3%) 
 
52(91.2%) 
 
9(3.7%) 
 
5(8.8%) 
 
 
            0.103 
 
 
 
TABLE : 20 
 
DURATION OF SURGERY 
                      SSI  
         P value 
    Absent     Present 
 
< 1 hr 
 
1 – 3 hrs 
 
> 3 hrs 
 
56(100%) 
 
213(96.8%) 
 
17(70.8%) 
 
0(0%) 
 
7(3.2%) 
 
7(29.2%) 
 
           <0.05 
 
TABLE : 21 
 
TYPE OF CLOSURE 
                      SSI  
         P value 
    Absent     Present 
 
Sutures 
 
Staplers 
 
281(95.9%) 
 
5(71.4%) 
 
12(4.1%) 
 
2(28.6%) 
 
            0.002 
 
           
 
 
TABLE : 22 
 
 
LENGTH OF POST-OP 
STAY 
                      SSI  
         P value 
    Absent     Present 
 
<5days 
 
5-10days 
 
>10days 
 
126(99.2%) 
 
121(96.0%) 
 
39(83.0%) 
 
1(0.8%) 
 
5(4.0%) 
 
8(17.0%) 
 
             
           <0.05 
 
  
  
 
 
 
 
                      DISCUSSION 
  
 
 
 
 
 
 
DISCUSSION: 
 
This study presents a randomised clinical and microbiological profile of 
surgical site infected wounds and two groups of patients using two different 
antiseptic preparations have been compared. 
As already discussed, surgical site infections increases mortality, morbidity 
and financial burden due to an increase in length of stay.  Surgical site infection 
represent about one fifth of all health care associated infections and in the most 
meticulous review of literature the infection rate is always higher(62). 
Preoperative disinfection of skin is one of the milestones for reducing 
surgical site infections and from 2010 Chlorhexidine-alcohol has been suggested to 
be superior to the classical Povidone Iodine disinfection.  We, therefore, made an 
effort to study the role of Chlorhexidine scrub on surgical site infection at PSG 
Hospitals, Coimbatore. 
The overall infection rate in the present study was 4.7% and compares 
favorably with other reported surgical site infection rates ranging from 2.5 to 
41.9%(65 to 72).  Number of studies carried out in India indicate an overall infection 
rate of 4.04 to 30% for clean surgeries and 10.06 to 45% for clean contaminated 
surgeries(66,68,71).  Findings in the present study showed that there is significant rise 
in infection rate with increased degree of operative contamination.  The rate of 
infection for clean surgeries was3.7%, while  in clean contaminated surgeries it 
was 8.8%. 
The average baseline rate of surgical site infection at six participating 
hospitals was 14% with Povidone Iodine skin preparation.  Our hypothesis was that 
substituting Chlorhexidine alcohol for Povidone Iodine would reduce the surgical 
site infection(74). 
The infection rates observed in Chlorhexidine and Povidone Iodine in 
present study were 1.3% and 8.0% respectively.  The difference in infection rates 
is statistically significant.  It was concluded that Chlorhexidine is superior to 
Povidone Iodine in surgical site anti-sepsis. 
In a prospective randomized clinical trial conducted between April 2004 and 
May 2008 at six university in united states, on a total of 809, the overall rate of 
surgical site infection was significantly lower in Chlorhexidine group than in the 
povidone iodine group(9.5%  vs  16.1%,  P value= 0.004).  Chlorhexidine was 
significantly more protective than Povidone Iodine against both superficial and 
deep incisional infections(75). 
A meta-analysis of clinical trials was conducted to determine whether 
preoperative antisepsis with Chlorhexidine or Povidone Iodine reduced surgical 
site infection in clean contaminated surgeries.  It concluded that Chlorhexidine 
reduced postoperative surgical site infection when compared with Povidone Iodine 
(pooled odd ratio- 0.68,P=0.019)(76). 
This study was conducted to determine if Chlorhexidine antiseptic scrub 
protocol reduces the rates of SSI’s in elective surgeries compared with Povidone-
Iodine antisepsis.  Patients undergoing elective surgeries from the department of 
General and G.I Surgery, Cardiothoracic and vascular surgery and Pediatric 
surgery were treated with either Chlorhexidine or Povidone Iodine for pre-
operative skin disinfection.  The rate of surgical site infection as defined by the 
centers for disease control and prevention (CDC), and the risk factors for the 
occurrence of surgical site infections were calculated.   
Antisepsis with Chlorhexidine was associated with a reduction in the overall 
rate of surgical site infections from  (8.0)  to  (1.3%) when compared with 
Povidone Iodine protocol (P=0.103).  The two groups of subjects were similar in 
regard to baseline characteristics and clinical history. 
Apart from the Povidone Iodine, risk factors found to be associated with 
surgical site infections were duration of surgery, type of closure, length of post 
operative stay.  In a retrospective study, risk factors like systemic hypertension and 
Type 2 Diabetes Mellitus have been found(77).  However, they were found not to be 
statistically significant. 
There was evidence from one study suggesting that pre-operative skin 
preparations with Chlorhexidine in methylated spirits led to a reduced risk of 
surgical site infections compared with an alcohol based Povidone Iodine 
solution(78). 
Nine randomized control trials were included in a meta-analysis which 
revealed that Chlorhexidine antisepsis was associated with significantly fewer 
surgical site infections and positive skin culture results than Iodine antisepsis(79).  
In this randomized study the application of Chlorhexidine reduced the risk of 
surgical site infection by 1.3% as compared with the most common practice in the 
United states of using Povidone-Iodine which is 8.0% in this study. 
Although both antiseptic preparations possess broad-spectrum antimicrobial 
activity, the superior clinical protection provided by Chlorhexidine is probably 
related to its more rapid action, persistent activity of despite exposure to bodily 
fluids and residual effects. 
The superior clinical efficacy of Chlorhexidine in our study correlates well 
with previous microbiological studies showing that chlorhexidine  based antiseptic 
preparations are more effective than Povidone Iodine containing solutions in the 
operative field.    
According to data from the NNIS system ,the distribution of pathogens 
isolated from surgical site infections has not changed markedly during the last 
decade.  Staphylococcus Aureus(80,81,82), Coagulase negative Staphylococci, 
Enterococcus spp.,and Escherichia Coli remain the most frequently isolated 
pathogens(83,84).  Pathogens commomly associated with wound infections and 
frequency of occurrence. 
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In our study the overall surgical site infection was found in 14patients out of 
which 12 from Povidone Iodine group and 2 from the Chlorhexidine group. The 
microbiological examination for all surgical site infected patients revealed positive 
organism growth for 7patients out of 14 patients and the remaining had no 
organism growth. 
The commonest organism found in this study was Escherichia coli  and 
followed by Klebsiella pneumonia  and Staphylococci species  
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Apart from the pre-operative skin antisepsis we also made an effort to 
analyse the risk factors involved in developing the surgical site infections.  We 
found by multi-variate analysis, the factors which influence the surgical site 
infection were type of surgery, duration of surgery and length of post-operative 
stay . 
In our study, length of postoperative stay had significance in developing 
surgical site infection.  As it was already mentioned in a previous study, prolonged 
stay with exposure to hospital environment has been shown to increase the rate of 
surgical site infection(73).  Prolonged postoperative hospitalization, which is a 
major concern, has been evident in patients developing surgical site infection(68). 
In the present study, duration of surgery had significance in developing 
surgical site infection.  The other studies reported that it has been observed that 
wound infection rate is influenced by duration of operation(65,67-69,72).  With increase 
in duration of surgery the rate of infection increased in direct proportion.  The 
results were found to be statistically significant. 
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CONCLUSION 
 
 Chlorhexidine scrub as a preoperative skin preparation had less number of 
surgical site infections when compared to Povidone Iodine. 
 
 Factors like duration of surgery, type of surgery and length of post operative 
stay had a significant impact in  development of surgical site infections. 
 
 Escherichia coli is the commonest isolate from the surgical site infected 
patients. 
 
 Surgical site infections are still a real risk for surgery and represent a 
substantial burden of disease for both patients and health care services in 
terms of morbidity ,mortality and economically. 
 
 Surveillance of Surgical site infections with feedback of appropriate data to 
surgeons would be desirable to reduce the Surgical site infection rates. 
 
 Chlorhexidine is commercially available in aqueous or alcohol formulations 
and has broad activity against gram positive and negative bacteria, anerobes, 
yeast and some lipid enveloped viruses. 
 
 Research has shown that surgical techniques, skin preparation and the 
timing, method of wound closure and length of hospital stay are significant 
factors that can influence of subsequent infection. 
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 Key points (coding) of master sheet 
  
 
 
 
 
 
 
Age:     
           <10years – 0  
             10-30 years – 1 
 30-50 years – 2 
 > 50 – 3 
 
Sex:  
            0 – Male 
 1 – Female 
 
SES: (socio economic status) 
   1 - Rs >3239 
            2 - Rs.1620-3239 
 3 - Rs.972 – 1620 
 4 – Rs.486 – 972 
 5 - Rs<486 
 
DEPT(department) 
 CTVS – Cardiothoracic and vascular surgery 
 PS – Paediatric Surgery 
 S1-6 – General Surgery 
 
BMI(Body mass Index) 
 0 - < 20 
 1 – 20-25 
 2 - > 25 
 
SITE (of the surgery) 
 0 – Abdomen 
 1 – Scrotum 
 2 – Groin 
 3 – Chest 
 4 – Perineum 
 5 – Limbs 
 6 – Back 
 7 – Breast 
 8 – Neck & Cheek 
 9 – Axilla 
 
CM - (Co moribidities) 
 0 – No Comornidities 
 1 – present 
 
P.H- (Personal Habits) – Smoking and Alcohol history 
            0 – No 
  1 – Yes 
 
Hb % - Hemoglobin level 
 
 
TOA – Type of Anaesthesia 
  GA – General Anaesthesia 
 SA – Spinal Anaesthesia 
 
 
 
 
 
 
 
 
 EA – Epidural Anaesthesia 
 
ASA – (American society of Anaesthesiology - 
grading1-6 ) 
 
SCRUB – (Pre operative skin preparation) 
 1 – Povidone Iodine 
 2 – Chlorhexidine 
 
DOS (Duration of surgery) 
 0 - < 1 hr 
 1 – 1 – 3 hrs 
 2 - > 3 hrs 
 
TOC (Type of closure) 
 1 – Sutures  
 2 – Staplers 
 
SSI (Surgical site infection) 
 0 – No evidence of SSI 
 1 – SSI present 
 
LOPS (Length of postoperative stay) 
 0  - <5days 
 1 – 5-10days 
 2 - >10days 
 
C/S : (Culture & sensitivity report) 
 0 - Sterile 
            1 – Escheriachia coli 
 2 – Klebsiella pneumonia 
 3 – Staphylococcus CONS 
 
 
S.NO IP NO AGE SEX DEPT BMI SES SITE CM P.H HB% TOA ASA SCRUB TOS DOS TOC SSI LOPS C/S 
1 I14025632 3 0 CTVS 1 2 3 1 0 12 GA 2 1 2 0 0 0 1  
2 I14025995 3 0 CTVS 1 2 3 1 0 13 GA 2 2 1 1 0 0 2  
3 I14025600 3 0 CTVS 1 4 3 1 1 11 GA 2 1 1 1 0 0 1  
4 I14025890 3 0 CTVS 2 3 3 1 0 9.8 GA 2 1 1 1 0 0 1  
5 I14025765 3 0 CTVS 0 4 5 0 1 12 GA 2 2 1 1 0 0 2  
6 I14026380 2 1 CTVS 2 3 3 1 0 13 GA 2 2 1 1 0 0 1  
7 I14026713 3 0 CTVS 2 4 3 0 0 16 GA 2 2 1 2 0 0 2  
8 I14026460  2 1 CTVS 1 3 3 0 0 11 GA 2 1 1 1 0 0 2  
9 I14026664 2 1 CTVS 1 4 3 0 0 9.9 GA 2 1 1 1 0 0 1  
10 I14026361 2 0 CTVS 1 3 3 0 0 11 GA 2 1 1 1 0 0 1  
11 I14026975 3 0 CTVS 1 4 3 1 0 7.7 GA 2 2 1 1 0 0 2  
12 I14030051 3 0 CTVS 0 3 3 1 1 13 GA 2 1 1 1 0 0 1  
13 I14027676 3 0 CTVS 1 3 3 1 0 9.9 GA 3 1 1 1 0 0 1  
14 I14027230 2 0 CTVS 2 2 3 0 0 11 GA 2 1 1 1 0 1 1 3 
15 I14027227 2 0 CTVS 1 3 3 0 0 12 GA 2 1 1 1 0 0 1  
16 I14027321 3 0 CTVS 0 4 3 1 1 6.9 GA 3 2 1 1 0 0 1  
17 I14028338 3 0 CTVS 1 2 3 0 0 10 GA 2 1 1 1 0 0 1  
18 I14028433 3 0 CTVS 1 4 3 0 1 13 GA 2 2 1 1 0 0 1  
19 I14027738 3 0 CTVS 2 4 3 1 0 7.4 GA 3 2 1 1 0 0 1  
20 I14027724 2 0 CTVS 2 3 3 1 0 13 GA 2 1 1 1 0 0 1  
21 I14028338 2 1 CTVS 2 3 3 1 0 12 GA 2 2 1 1 0 0 1  
22 I14028064 3 0 CTVS 2 4 3 1 1 16 GA 2 1 1 1 0 0 2  
23 I14028433 2 0 CTVS 1 4 3 0 1 16 GA 2 2 1 1 0 0 2  
24 I14027908 3 0 CTVS 2 4 3 0 0 15 GA 2 2 1 1 0 0 1  
25 I14028300 3 0 CTVS 2 3 3 1 0 12 GA 3 1 1 1 0 1 2 0 
26 I14028745 3 0 CTVS 2 3 3 0 0 11 GA 2 1 1 1 0 0 1  
27 I14028668 3 0 CTVS 2 3 3 1 0 12 GA 2 1 1 1 0 0 1  
28 I14029001 2 0 CTVS 1 3 3 1 1 12 GA 3 1 1 2 0 1 1 1 
29 I14029316 2 0 CTVS 1 3 3 0 0 15 GA 2 2 1 1 0 0 1  
30 I14028653 3 0 CTVS 1 3 3 1 0 15 GA 3 2 1 1 0 0 1  
31 I14029252 3 0 CTVS 2 3 3 1 0 14 GA 3 2 1 1 0 0 1  
32 I14029933 3 0 CTVS 1 4 3 0 1 13 GA 2 1 1 1 0 0 2  
33 I14030051 3 0 CTVS 1 3 3 1 1 13 GA 3 1 1 1 0 0 1  
34 I14030319 3 0 CTVS 2 4 3 1 0 14 GA 2 1 1 1 0 0 1  
35 I14030229 1 1 CTVS 0 3 3 0 0 14 GA 2 1 1 1 0 0 1  
36 I14030174 1 1 CTVS 0 3 3 0 0 13 GA 2 1 1 1 0 0 1  
37 I14030233 3 1 CTVS 2 3 3 1 0 12 GA 2 1 1 0 0 0 0  
38 I14030396 3 0 CTVS 2 3 3 1 1 14 GA 3 2 1 1 0 0 1  
39 I14030933 2 0 CTVS 2 3 3 0 1 17 GA 2 2 1 1 0 0 1  
40 I14031049 3 0 CTVS 1 2 3 1 1 11 GA 3 1 1 1 0 0 1  
41 I14031071 2 0 CTVS 2 4 3 0 0 12 GA 2 1 1 1 0 0 2  
42 I14031615 3 0 CTVS 2 3 3 0 0 12 GA 2 1 1 1 0 0 2  
43 I14031640 3 1 CTVS 2 3 3 1 1 11 GA 3 2 1 1 0 0 1  
44 I14032080 3 1 CTVS 1 1 3 0 0 12 GA 2 1 1 1 0 0 2  
45 I14031985 2 0 CTVS 0 4 3 0 1 11 GA 2 1 1 1 0 0 2  
46 I14031972 3 0 CTVS 1 3 3 1 0 9 GA 3 2 1 1 0 0 1  
47 I14032508 2 0 CTVS 1 1 5 0 1 17 GA 2 2 1 1 0 0 1  
48 I14032381 3 0 CTVS 0 2 3 0 0 9.5 GA 2 1 1 2 0 0 1  
49 I14032570 2 1 CTVS 1 1 3 0 0 13 GA 2 2 1 1 0 0 1  
50 I14032374 3 0 CTVS 0 2 3 1 1 15 GA 3 2 1 1 0 0 1  
51 I14032600 2 1 CTVS 0 2 3 1 0 12 GA 2 2 1 1 0 0 1  
52 I14033226 3 1 CTVS 1 2 3 1 0 11 GA 2 1 1 1 0 0 1  
53 I14033004 3 0 CTVS 1 2 3 0 0 13 GA 3 2 1 1 0 0 1  
54 I1403285 2 0 CTVS 2 3 3 1 0 12 GA 3 1 1 1 0 0 1  
55 I14032916 2 0 CTVS 1 3 5 0 1 11 GA 2 2 1 1 0 0 2  
56 I14032900 0 1 CTVS 0 2 3 0 0 13 GA 2 1 1 1 0 0 1  
57 I14033230 3 0 CTVS 1 2 3 0 0 13 GA 2 2 1 1 0 0 1  
58 I14033447 2 0 CTVS 1 3 3 1 0 16 GA 3 1 1 1 0 0 1  
59 I14032998 2 1 CTVS 2 2 3 0 0 13 GA 2 2 1 1 0 0 1  
60 I14033683 2 0 CTVS 1 2 3 1 1 13 GA 2 1 1 1 0 0 1  
61 I14033960 2 0 CTVS 1 3 3 1 0 11 GA 3 1 1 1 0 0 1  
62 I14033927 3 1 CTVS 2 3 3 1 0 14 GA 3 2 1 1 0 1 1 0 
63 I14034057 3 0 CTVS 1 2 3 0 0 15 GA 2 2 1 1 0 0 1  
64 I14033833 3 0 CTVS 1 3 3 1 1 14 GA 3 2 1 1 0 0 1  
65 I14033841 3 0 CTVS 1 2 3 1 0 12 GA 2 2 1 1 0 0 1  
66 I14034243 3 1 CTVS 2 3 3 1 0 12 GA 2 1 1 1 0 0 1  
67 I14034340 3 0 CTVS 2 3 3 0 1 15 GA 2 2 1 1 0 0 1  
68 I14034751 3 0 CTVS 1 4 3 1 1 12 GA 2 1 1 1 0 0 1  
69 I14034880 2 0 CTVS 1 4 3 0 1 10 GA 2 2 1 1 0 0 1  
70 I14034972 2 0 CTVS 1 3 3 0 1 15 GA 2 1 1 1 0 0 1  
71 I14034533 3 0 CTVS 2 3 3 0 1 12 GA 2 1 1 1 0 0 1  
72 I14035233 3 1 CTVS 2 3 3 1 0 11 GA 3 1 1 1 0 0 1  
73 I14035151 3 1 CTVS 1 3 5 1 0 15 GA 2 2 1 1 0 0 1  
74 I14034747 3 0 CTVS 2 2 3 1 0 13 GA 3 1 1 2 0 0 2  
75 I14035150 3 0 CTVS 0 4 3 0 1 9.9 GA 3 2 1 1 0 0 1  
76 I14034537 3 0 CTVS 2 3 3 0 0 14 GA 2 2 1 2 0 0 2  
77 14035358 3 0 CTVS 1 3 5 1 1 12 GA 3 2 2 1 0 0 1  
78 I14035119 3 0 CTVS 1 2 3 0 1 15 GA 2 1 1 1 0 0 1  
79 I14032589 3 0 CTVS 1 3 3 1 0 14 GA 2 2 1 1 0 0 2  
80 I14035920 3 0 CTVS 2 3 3 1 1 15 GA 3 1 1 1 0 0 2  
81 14036128 3 0 CTVS 2 3 3 1 1 13 GA 3 1 1 2 0 0 2  
82 I14036579 3 0 CTVS 1 1 3 1 1 13 GA 3 2 1 1 0 0 2  
83 I14036227 3 0 CTVS 2 4 3 0 1 13 GA 3 1 1 2 0 0 1  
84 I14036584 3 0 CTVS 1 3 5 1 1 11 GA 3 2 1 1 0 0 1  
85 I14036783 3 0 CTVS 1 2 3 1 1 14 GA 2 2 1 1 0 0 1  
86 I14035652 3 0 CTVS 2 3 3 1 1 14 GA 3 2 1 2 0 0 0  
87 I14036761 3 0 CTVS 1 2 3 0 1 16 GA 2 2 1 1 0 0 1  
88 I14036917 3 0 CTVS 1 3 3 1 1 15 GA 3 2 1 1 0 0 1  
89 I14036714 3 0 CTVS 1 3 3 1 1 12 GA 3 2 1 1 0 0 1  
90 I14037037 2 0 CTVS 2 3 3 1 1 14 GA 3 2 1 1 0 0 1  
91 I14037433 2 1 CTVS 0 2 3 1 0 9.7 GA 3 1 1 1 0 0 1  
92 I14037093 3 0 CTVS 1 3 3 0 1 14 GA 3 2 1 1 0 0 2  
93 I15000145 3 1 CTVS 1 2 3 1 0 9.8 GA 2 1 1 1 0 0 1  
94 I14037480 3 1 CTVS 1 3 3 1 0 12 GA 3 2 1 1 0 0 1  
95 I14037679 3 0 CTVS 1 2 3 1 1 15 GA 3 2 1 1 0 0 1  
96 I15000541 3 0 CTVS 1 2 3 1 0 14 GA 2 1 1 1 0 1 1 0 
97 I15000457 2 1 CTVS 0 2 3 1 0 13 GA 2 2 1 1 0 0 1  
98 I14037687 3 0 CTVS 1 3 5 1 0 15 GA 2 1 1 1 0 0 2  
99 I14037680 2 0 CTVS 1 3 3 1 0 11 GA 2 2 1 1 0 0 1  
100 I15000584 2 1 CTVS 1 2 3 0 0 14 GA 2 1 1 1 0 0 1  
101 I14024772 0 0 PS-3 7 3 4 0 0 12 GA 1 1 2 2 0 0 2  
102 I14024778 0 0 PS-3 8 2 1 0 0 11 GA 1 2 1 0 0 0 0  
103 I14024961 0 0 PS-3 4 1 0 0 0 15 GA 2 2 2 0 0 0 0  
104 I14025135 0 0 PS-2 11 2 2 0 0 13 GA 1 1 1 0 0 0 1  
105 I14025850 1 0 PS-3 38 2 2 0 0 14 GA 2 2 1 0 0 0 0  
106 I14025939 0 1 PS-3 9.3 3 3 0 0 13 GA 2 1 1 0 0 0 0  
107 I14025880 0 0 PS-3 8.1 3 1 0 0 12 GA 1 2 1 0 0 0 0  
108 I14025958 0 1 PS-3 8.7 3 4 1 0 13 GA 2 1 2 2 0 0 1  
109 I14026034 0 0 PS-3 11 3 2 0 0 12 GA 2 2 1 1 0 0 0  
110 I14026366 0 0 PS-3 15 2 4 0 0 10 GA 2 1 2 2 0 0 2  
111 I14026511 0 0 PS-2 21 1 5 0 0 12 GA 2 2 1 0 0 0 0  
112 I14026560 0 0 PS-3 24 3 4 0 0 12 GA 1 2 2 1 0 0 1  
113 I14026559 0 0 PS-3 12 3 0 0 0 14 GA 2 2 2 1 0 0 1  
114 I14026859 0 0 PS-3 14 3 2 0 0 14 GA 2 2 1 0 0 0 0  
115 I14026860 0 0 PS-3 8.7 4 1 0 0 10 GA 2 2 1 0 0 0 0  
116 I14026862 0 0 PS-2 19 1 2 0 0 13 GA 2 2 1 0 0 0 0  
117 I14026601 0 0 PS-3 4.3 3 0 0 0 10 GA 2 1 2 1 0 0 2  
118 I14027218 0 0 PS-3 4.3 3 6 0 0 11 GA 2 1 1 1 0 0 1  
119 I14027333 0 0 PS-2 15 2 5 0 0 12 GA 2 2 1 0 0 0 0  
120 I14027632 0 0 PS-3 15 1 1 0 0 13 GA 2 2 1 0 0 0 0  
121 I14027094 0 0 PS-3 11 4 0 0 0 11 GA 1 2 2 1 0 0 1  
122 I14027692 0 0 PS-3 19 3 1 0 0 9.5 GA 2 2 1 0 0 0 0  
123 I14027840 0 0 PS-3 3.6 2 2 0 0 11 GA 2 1 1 1 0 0 0  
124 I14028830 0 0 PS-1 8.9 3 2 0 0 11 GA 1 1 1 1 0 0 0  
125 I14029126 0 0 PS-3 5.3 3 0 0 0 8.6 GA 2 1 2 0 0 0 0  
126 I14029332 1 0 PS-3 27 2 2 0 0 12 GA 2 2 1 0 0 0 0  
127 I14029347 0 0 PS-1 8 2 1 0 0 9.7 GA 2 2 1 0 0 0 0  
128 I14029355 0 1 PS-3 7.6 3 2 0 0 11 GA 2 2 1 0 0 0 0  
129 I14029455 0 0 PS-2 2.7 3 3 1 0 17 GA 2 1 2 1 0 1 2 0 
130 I14029430 0 1 PS-3 3.9 4 3 0 0 11 GA 2 2 1 1 0 0 1  
131 I14029438 0 0 PS-1 6.6 3 0 0 0 9.8 GA 2 2 2 1 0 0 1  
132 I14029844 0 0 PS-3 30 3 2 0 0 12 GA 2 1 1 1 0 0 0  
133 I14029874 0 0 PS-3 10 2 1 0 0 13 GA 1 2 1 0 0 0 0  
134 I14030103 1 0 PS-1 29 3 2 1 0 13 GA 2 2 1 0 0 0 0  
135 I14030625 0 0 PS-3 2.4 3 3 1 0 14 GA 3 2 2 1 0 0 2  
136 I14030721 0 0 PS-3 12 2 4 0 0 11 GA 2 1 2 1 0 0 1  
137 I14030902 0 0 PS-3 6.7 3 3 0 0 11 GA 2 2 1 0 0 0 0  
138 I14030580 0 0 PS-1 11 3 0 0 0 12 GA 2 1 2 2 0 1 2 0 
139 I14030719 0 0 PS-3 18 3 4 0 0 13 GA 2 2 1 1 0 0 0  
140 I14031643 0 0 PS-3 8.9 3 0 0 0 11 GA 2 2 2 1 0 0 0  
141 I14031388 0 1 PS-3 5.9 2 0 0 0 11 GA 2 1 2 1 0 0 0  
142 I14031563 0 1 PS-3 8 3 0 0 0 12 GA 2 1 2 2 0 0 1  
143 I14031797 0 0 PS-1 12 4 0 0 0 10 GA 2 1 2 2 0 0 2  
144 I14031449 0 1 PS-3 13 3 0 0 0 13 GA 2 2 2 1 0 0 1  
145 I14032316 1 0 PS-3 51 1 1 0 0 15 GA 2 2 2 1 0 0 2  
146 I14033019 0 0 PS-3 9.6 3 1 0 0 12 GA 2 1 1 1 0 0 0  
147 I14033526 0 0 PS-2 12 2 1 0 0 8.8 GA 1 2 1 0 0 0 0  
148 I14034261 0 0 PS-3 11 1 4 0 0 12 GA 2 1 2 1 0 0 0  
149 I14033238 0 0 PS-3 15 2 1 0 0 12 GA 1 2 1 1 0 0 0  
150 I14033716 0 0 PS-3 3 3 2 0 0 15 GA 1 2 1 0 0 0 0  
151 I14033978 0 1 PS-3 4.9 3 0 0 0 13 GA 2 2 1 2 0 0 1  
152 I14034536 0 0 PS-2 3.9 3 0 0 0 11 GA 2 1 2 1 0 0 1  
153 I14034881 0 0 PS-3 13 2 0 0 0 11 GA 2 1 2 1 0 0 2  
154 I14035173 0 0 PS-3 9.5 3 1 0 0 11 GA 1 2 2 0 0 0 0  
155 I14035148 0 0 PS-1 15 4 4 0 0 11 GA 2 1 2 1 0 0 0  
156 I14035338 0 1 PS-3 17 3 0 0 0 9.2 GA 1 1 2 1 0 0 0  
157 I14035330 0 0 PS-3 8.8 1 1 0 0 9.9 GA 1 2 1 0 0 0 0  
158 I14035575 0 1 PS-1 8.5 3 0 0 0 9.8 GA 1 1 2 1 0 0 1  
159 I14035988 0 0 PS-3 5.6 3 0 0 0 11 GA 2 2 2 1 0 0 0  
160 I14035972 0 1 PS-2 3.5 2 0 0 0 10 GA 2 1 2 1 0 0 0  
161 I14035993 0 0 PS-3 15 3 2 0 0 12 GA 1 2 1 0 0 0 0  
162 I14036366 0 0 PS-3 2.9 3 0 0 0 13 GA 2 2 1 1 0 0 0  
163 I14036333 0 0 PS-2 4.4 3 0 0 0 9.7 GA 2 1 2 1 0 0 1  
164 I14037072 1 1 PS-1 36 2 4 0 0 14 GA 2 1 2 1 0 0 0  
165 I14037178 0 0 PS-2 7.8 3 0 0 0 11 GA 2 1 2 1 0 0 0  
166 I14037110 1 0 PS-1 24 1 1 0 0 11 GA 1 1 1 0 0 0 0  
167 II14037494 0 0 PS-1 10 3 2 0 0 11 GA 1 1 1 0 0 0 0  
168 I14037569 0 0 PS-2 22 3 0 0 0 14 GA 2 1 1 1 0 0 0  
169 I15000042 0 0 PS-2 15 2 4 0 0 13 GA 1 1 1 0 0 0 0  
170 I15000766 0 0 PS-3 11 3 4 0 0 12 GA 1 1 2 1 0 0 1  
171 I15000750 0 0 PS-3 8 2 5 0 0 12 GA 1 1 1 1 0 0 1  
172 I15000833 1 0 PS-3 29 1 5 0 0 12 GA 1 1 1 1 0 0 0  
173 I15001009 0 0 PS-3 8.3 1 1 0 0 12 GA 1 2 1 1 0 0 0  
174 I15001237 1 1 PS-2 39 2 7 0 0 13 GA 2 2 1 1 0 0 0  
175 I14037233 0 0 PS-3 5.2 3 0 0 0 9.6 GA 2 1 2 1 0 0 2  
176 I15001549 0 0 PS-3 12 3 4 0 0 12 GA 2 2 2 1 0 0 1  
177 I15001608 0 1 PS-3 4.3 2 2 0 0 11 GA 2 2 1 1 0 0 0  
178 I15001536 0 0 PS-3 4.6 3 0 0 0 10 GA 2 2 2 1 0 0 0  
179 I15001543 0 0 PS-3 7.4 2 0 0 0 12 GA 2 1 2 1 0 0 1  
180 I15002112 0 0 PS-3 5.5 2 1 0 0 9.6 GA 2 2 1 1 0 0 0  
181 I15001935 0 0 PS-3 9.6 1 0 0 0 11 GA 2 2 2 1 0 0 0  
182 I15002698 0 0 PS-1 7.8 2 4 0 0 11 GA 2 2 2 1 0 0 1  
183 I15002925 0 0 PS-2 8.8 3 0 0 0 11 GA 1 2 2 1 0 0 1  
184 I15003331 0 0 PS-2 18 2 2 0 0 13 GA 1 2 1 0 0 0 0  
185 I15003753 0 0 PS-3 4 1 2 0 0 8.9 GA 1 1 1 0 0 0 0  
186 I15004353 0 0 PS-3 4.9 3 0 0 0 10 GA 2 1 2 1 0 0 1  
187 I15004549 0 0 PS-3 15 2 1 0 0 11 GA 2 2 1 0 0 0 0  
188 I15004968 0 0 PS-3 8.1 2 2 0 0 16 GA 1 1 1 0 0 0 0  
189 I15005212 0 0 PS-3 3 3 2 0 0 20 GA 2 2 1 1 0 0 0  
190 I15005892 0 0 PS-3 2.2 3 2 0 0 9.2 GA 2 1 1 1 0 0 0  
191 I15006108 0 0 PS-2 5.9 2 0 0 0 14 GA 2 1 2 1 0 0 0  
192 I15006325 0 0 PS-2 19 1 4 0 0 12 GA 1 1 2 1 0 0 1  
193 I15006796 1 0 PS-2 39 2 1 0 0 15 GA 1 1 1 1 0 0 0  
194 I15007021 0 1 PS-2 7.7 3 6 0 0 12 GA 1 1 1 1 0 0 0  
195 I15006622 0 0 PS-3 18 2 8 0 0 13 GA 1 1 1 0 0 0 0  
196 I15007154 0 0 PS-1 3.4 1 2 0 0 11 GA 2 1 1 0 0 0 0  
197 I15007411 0 0 PS-3 12 3 0 0 0 12 GA 1 2 2 1 0 0 1  
198 I15007581 0 0 PS-2 7.5 3 0 0 0 11 GA 2 1 2 1 0 0 1  
199 I15007611 0 0 PS-1 3.9 2 0 0 0 16 GA 2 1 2 1 0 0 1  
200 I15008015 0 0 PS-3 10 2 9 0 0 11 GA 1 1 1 0 0 0 0  
201 I14030178 3 0 S1 1 3 2 1 0 12 SA 2 1 1 1 0 0 0  
202 I14030200 3 1 S1 1 2 8 0 0 11 GA 1 2 1 1 0 0 0  
203 I14030326 2 1 S2 1 3 8 0 0 13 GA 1 1 1 1 0 0 0  
204 I14030388 2 1 S1 1 2 8 1 0 13 GA 2 2 1 1 0 0 0  
205 I14030382 2 0 S4 1 3 0 0 1 13 GA 2 1 2 2 1 1 2 1 
206 I14031237 3 0 S6 1 2 0 0 0 14 SA 1 2 1 1 0 0 1  
207 I14032081 2 1 S6 1 2 5 1 0 12 RA 3 1 1 0 0 0 0  
208 I14030828 3 1 S6 2 1 7 0 0 12 GA 2 2 1 1 1 0 1  
209 I14030828 3 1 S6 2 3 7 0 0 12 GA 2 2 1 1 1 0 2  
210 I14031607 3 1 S6 1 4 0 1 0 12 SA 2 2 1 0 0 0 0  
211 I14031624 2 0 S6 1 1 0 0 0 15 SA 2 2 1 0 0 0 1  
212 I14032098 1 0 S6 2 3 0 0 0 15 GA 2 1 2 2 0 0 2  
213 I14031927 2 1 S5 2 2 2 0 0 12 GA 1 2 1 1 0 0 1  
214 I14033412 2 0 S3 2 3 2 0 0 14 SA 1 1 1 1 0 0 1  
215 I14033440 2 0 S6 1 1 5 1 1 15 SA 2 2 1 1 0 0 0  
216 I14033655 2 1 S2 1 3 7 0 0 9.2 GA 1 1 1 0 0 0 0  
217 I14033412 2 0 S3 1 2 2 0 1 14 SA 1 2 1 1 0 0 1  
218 I14036722 3 0 S6 2 3 2 0 1 15 SA 2 1 1 0 0 0 0  
219 I14033412 2 0 S3 1 2 2 0 0 14 SA 1 2 1 1 0 0 0  
220 I14034027 3 0 S5 1 1 2 1 1 11 SA 2 2 1 0 0 0 1  
221 I14033599 3 1 S6 1 4 0 0 0 10 GA 2 1 2 2 0 1 2 1 
222 I14034312 3 0 S1 2 2 2 0 1 15 SA 1 2 1 1 0 0 0  
223 I14034826 2 0 S4 2 3 2 0 1 13 SA 1 2 1 1 1 0 0  
224 I14034780 3 0 S4 1 4 2 1 1 12 SA 2 2 1 1 1 0 0  
225 I14035141 2 1 S5 1 2 7 1 0 12 GA 2 1 1 0 0 0 0  
226 I14035144 2 1 S1 1 3 2 1 0 13 GA 2 2 1 1 0 0 0  
227 I14035149 2 1 S1 1 2 8 1 0 12 GA 2 1 1 1 0 0 0  
228 I14035096 2 0 S4 1 3 0 0 0 16 SA 1 2 1 1 0 0 0  
229 I14035176 2 0 S5 1 4 5 0 1 16 SA 1 1 1 1 0 0 1  
230 I14034846 2 0 S5 1 2 2 1 0 17 SA/EA 2 2 1 1 0 0 1  
231 I14034517 3 0 S5 1 3 2 1 1 13 SA 2 1 1 1 0 0 1  
232 I14035428 2 0 S6 1 1 0 0 1 16 GA 2 2 2 2 1 1 2 0 
233 I14036438 3 0 S6 2 2 2 1 0 16 SA 2 1 1 1 0 1 0 0 
234 I14035091 3 0 S4 2 2 2 1 1 9.8 SA 2 1 1 1 0 0 0  
235 I14036438 3 0 S4 2 3 2 1 0 12 SA 2 2 1 1 1 0 1  
236 I14036597 1 1 S6 1 1 8 0 0 11 GA 2 2 1 1 0 0 0  
237 I14035760 3 0 S6 1 3 8 0 1 12 LA 1 2 1 0 0 0 1  
238 I14037085 3 0 S2 2 3 5 1 1 12 GA 2 2 1 0 0 0 0  
239 I14036967 2 1 S2 2 3 8 0 0 12 GA 1 1 1 1 0 0 0  
240 I14037164 2 1 S5 1 3 7 0 0 13 GA 1 1 1 1 0 0 0  
241 I14037573 3 0 S2 2 3 2 0 1 12 SA 1 2 1 1 0 0 1  
242 I15000408 2 1 S5 1 3 7 0 0 11 GA 1 1 1 1 0 0 0  
243 I15000870 3 1 S5 1 2 7 1 0 12 GA 2 1 1 0 0 0 0  
244 I15001682 2 1 S4 1 2 8 0 0 12 GA 1 2 1 1 0 0 0  
245 I15000901 1 0 S1 1 2 2 0 0 15 SA 1 1 1 1 0 0 1  
246 I15001755 3 0 S2 1 4 2 0 1 15 SA 1 1 1 0 0 0 0  
247 I15001908 2 0 S2 1 2 0 1 1 14 SA 2 1 1 1 0 0 0  
248 I15002022 2 0 S6 1 2 5 0 0 15 GA 1 2 1 0 0 0 0  
249 I15002099 2 0 S2 1 3 5 0 0 15 SA 1 1 1 1 0 0 0  
250 I15002211 2 1 S5 2 3 5 0 0 12 GA 1 1 1 0 0 0 0  
251 I15002969 3 1 S5 1 3 5 0 0 12 SA 1 1 1 1 0 0 0  
252 I15003026 2 1 S5 0 3 2 0 0 12 SA 1 2 1 1 0 0 1  
253 I15004183 2 1 S5 0 1 7 0 0 12 GA 1 1 1 0 0 0 0  
254 I15004307 3 1 S3 2 2 0 1 0 11 SA 2 1 1 1 0 1 2 2 
255 I15004635 2 1 S6 2 3 8 0 0 14 GA 1 2 1 1 0 0 0  
256 I15005534 2 1 S5 1 2 0 0 0 13 SA/EA 1 1 1 1 0 0 2  
257 I15009454 2 0 S4 1 4 8 1 0 12 GA 2 2 1 1 0 0 0  
258 I15006085 3 0 S5 1 2 2 1 1 14 SA 2 1 1 1 0 0 1  
259 I15005239 2 0 S5 1 3 5 0 0 14 SA 1 1 1 1 0 0 2  
260 I15005707 2 1 S6 1 3 0 1 0 12 GA 2 2 2 1 0 0 1  
261 I15004790 2 1 S6 2 3 5 0 0 12 SA 1 2 1 0 0 0 1  
262 I15005346 2 0 S5 1 3 2 0 1 16 SA 2 1 1 1 0 0 1  
263 I15006097 2 1 S4 1 3 0 1 0 12 GA 2 2 2 2 0 0 2  
264 I15005926 3 0 S4 2 2 2 1 0 12 SA 2 2 1 1 0 0 0  
265 I15005550 2 0 S4 1 3 5 0 0 15 SA 1 1 1 1 0 0 0  
266 I15005345 2 1 S6 1 3 8 0 0 8.6 GA 1 2 1 1 0 0 0  
267 I15006133 3 0 S2 2 3 0 0 0 14 SA 2 1 1 2 0 1 2 1&2 
268 I15007118 3 1 S4 0 4 0 0 0 13 GA 1 1 2 2 0 0 2  
269 I15006977 3 0 S5 1 3 0 1 1 14 SA 2 1 1 1 0 0 1  
270 I15007403 3 1 S3 2 2 7 1 0 12 GA 2 1 1 1 0 0 2  
271 I15007669 3 0 S5 1 2 2 1 0 12 SA 3 2 1 1 0 0 0  
272 I15007441 2 1 S3 1 3 8 1 0 13 GA 2 1 1 1 0 0 1  
273 I15007562 3 0 S4 1 2 0 0 0 5.8 GA 1 1 2 1 0 0 2  
274 I15007955 3 0 S4 1 3 8 1 0 13 GA 2 1 1 1 0 0 0  
275 I15007518 2 0 S4 0 3 2 0 0 17 SA 1 2 1 1 0 0 0  
276 I15008263 1 0 S4 0 3 1 0 0 15 SA 1 1 1 1 0 0 0  
277 I15007764 2 0 S4 1 4 0 0 0 7.2 GA 1 2 2 2 0 0 2  
278 I15008716 3 1 S4 1 3 8 1 0 12 GA 2 2 1 1 0 0 0  
279 I15009028 1 1 S4 1 3 8 0 0 12 GA 1 1 1 1 0 0 0  
280 I15008558 2 1 S6 1 3 8 0 0 13 GA 1 1 1 1 0 0 0  
281 I15009155 2 0 S4 1 2 0 1 0 13 SA 2 2 1 1 0 0 0  
282 I15009454 2 0 S4 1 4 8 1 0 12 GA 2 2 1 1 0 0 0  
283 I15009244 3 1 S4 1 3 7 0 0 12 GA 1 2 1 1 0 0 0  
284 I15009420 3 1 S4 2 2 0 1 0 14 SA+EA 2 1 1 2 0 1 1 1 
285 I15009193 3 1 S5 1 3 2 1 1 11 SA 2 2 1 1 0 0 1  
286 I15009182 2 1 S2 1 4 8 0 0 12 GA 1 1 1 1 0 0 2  
287 I15009609 2 1 S6 1 2 8 0 0 12 GA 1 2 1 1 0 0 0  
288 I15009669 3 0 S2 1 3 8 1 0 11 GA 2 1 1 1 0 0 0  
289 I15009826 3 1 S4 1 2 7 1 0 12 GA 2 2 1 1 0 0 0  
290 I15009866 3 0 S4 1 4 2 1 1 16 SA 2 2 1 1 0 0 0  
291 I15009953 3 1 S6 1 2 7 0 0 11 GA 1 1 1 0 0 0 0  
292 I15009731 2 0 S4 1 1 1 0 0 13 SA 1 2 1 1 0 0 0  
293 I15010128 1 1 S4 1 2 7 0 0 14 GA 1 1 1 0 0 0 0  
294 I15010105 2 1 S4 2 3 7 0 0 12 GA 1 2 1 0 0 0 0  
295 I15010091 3 0 S1 1 3 2 0 1 12 SA 1 2 1 1 0 0 0  
296 I15010268 3 1 S1 1 2 7 1 0 11 GA 2 1 1 0 0 0 0  
297 I15010221 2 1 S2 2 3 0 1 0 11 SA 2 2 1 1 0 0 1  
298 I15010208 3 1 S4 1 2 5 0 0 11 SA 1 1 1 1 0 0 0  
299 I15010391 2 1 S4 1 1 7 1 0 12 GA 2 1 1 1 0 0 0  
 300 I15010637 2 1 S6 2 3 0 1 0 12 GA 2 2 1 1 0 0 0   
